Pharmacokinetic, Safety and Immunogenicity Phase I Study of HLX14 Versus Prolia® in Healthy Male Subjects
Clinical trial NCT04534582 · COMPLETED
Trial details
- NCT number
- NCT04534582
- Sponsor
- Shanghai Henlius Biotech
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-03
- Primary completion
- 2023-09-12
- Enrollment
- 252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.